Proprietary Formulation Technologies Advancing in Preclinical Drug Development
New Report by Applied Data Research Analyzes the Impact on Drug Development Timelines
(Nashua, NH) – As the availability of new tools for automating the drug discovery process identifies potential drug candidates at an accelerating rate, the formulation limitations of a majority of these new NCEs is creating a bottleneck in preclinical development. Drug developers are responding by exploring drug formulation technologies – often proprietary processes offered by third parties – to negotiate their way past critical steps in the path to commercializing new chemical entities and driving the financial success of their companies.
Much of the current focus in formulation science is concerned with processes that can improve the solubility of APIs. The importance of solubilization technologies is also underscored by the capability they bestow on formulators attempting to re-formulate approved drugs approaching the end of their patent life.
Issues surrounding water insolubility of active compounds have important business and market implications for new drug development. This impact goes beyond potential future drug therapeutics, effectively limiting reformulation strategies for existing products at a time when extending the market life of proprietary drugs through derivative formulations has become a key business strategy.
Drug formulation technology companies are working with drug developers at pharmaceutical companies to help define the prescription formulations that will enter preclinical development and the clinical trial pipeline in the coming months and years. New formulation capabilities will expand the number of new NCEs that can be formulated to meet pharmacochemical thresholds.
More information is available at www.applieddata.org .
About Applied Data
Applied Data Research is a drug therapeutics consulting firm focused on medical market strategies, product commercialization, venture development, and market research. We assist medical market participants in achieving their business objectives through the creation of detailed business development strategies, product commercialization programs, and comprehensive market and technology research and analysis.
Contact:
Greg Stone
Voice: 603-595-6225
Fax: 603-804-0466
www.applieddata.org
Source: Applied Data Research
